BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 27067600)

  • 1. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
    Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
    Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine ADP-Ribosylation Depends on HPF1.
    Bonfiglio JJ; Fontana P; Zhang Q; Colby T; Gibbs-Seymour I; Atanassov I; Bartlett E; Zaja R; Ahel I; Matic I
    Mol Cell; 2017 Mar; 65(5):932-940.e6. PubMed ID: 28190768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
    Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
    Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
    Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
    Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
    Dhakar SS; Galera-Prat A; Lehtiö L
    Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.
    Hendriks IA; Buch-Larsen SC; Prokhorova E; Elsborg JD; Rebak AKLFS; Zhu K; Ahel D; Lukas C; Ahel I; Nielsen ML
    Nat Commun; 2021 Oct; 12(1):5893. PubMed ID: 34625544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
    Rudolph J; Roberts G; Muthurajan UM; Luger K
    Elife; 2021 Mar; 10():. PubMed ID: 33683197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
    Rudolph J; Roberts G; Luger K
    Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTS discovery of PARP1-HPF1 complex inhibitors in cancer.
    Kellett T; Noor R; Zhou Q; Esquer H; Sala R; Stojanovic P; Rudolph J; Luger K; LaBarbera DV
    SLAS Discov; 2023 Dec; 28(8):394-401. PubMed ID: 37844763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine ADP-ribosylation reversal by the hydrolase ARH3.
    Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
    Elife; 2017 Jun; 6():. PubMed ID: 28650317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1/2 and Accessory Factor HPF1 Interlock to Form a Joint Active Site.
    Cancer Discov; 2020 Apr; 10(4):486. PubMed ID: 32060056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
    Longarini EJ; Dauben H; Locatelli C; Wondisford AR; Smith R; Muench C; Kolvenbach A; Lynskey ML; Pope A; Bonfiglio JJ; Jurado EP; Fajka-Boja R; Colby T; Schuller M; Ahel I; Timinszky G; O'Sullivan RJ; Huet S; Matic I
    Mol Cell; 2023 May; 83(10):1743-1760.e11. PubMed ID: 37116497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine is the major residue for ADP-ribosylation upon DNA damage.
    Palazzo L; Leidecker O; Prokhorova E; Dauben H; Matic I; Ahel I
    Elife; 2018 Feb; 7():. PubMed ID: 29480802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.
    Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E
    DNA Repair (Amst); 2010 Jun; 9(6):627-35. PubMed ID: 20303835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.